Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): Effects on anandamide and oleoylethanolamide deactivation

Journal of Pharmacology and Experimental Therapeutics

Volumn 313, Issue 1, 2005, Pages 352-358

  Fegley, Darren ^a   Gaetani, Silvana ^a   Duranti, Andrea ^b   Tontini, Andrea ^b   Mor, Marco ^c   Tarzia, Giorgio ^b   Piomelli, Daniele ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF URBINO   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DRUG VEHICLE; ENZYME INHIBITOR; FATTY ACID AMIDASE INHIBITOR; N OLEOYLETHANOLAMINE; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; DRUG EFFECT; DRUG HYDROLYSIS; DRUG RESPONSE; DUODENUM; ENZYME ACTIVITY; FAAH GENE; GENE; GENE DELETION; MALE; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; RAT; SATIETY; WILD TYPE;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; BENZAMIDES; BODY TEMPERATURE; BRAIN; CALCIUM CHANNEL BLOCKERS; CARBAMATES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG SYNERGISM; DUODENUM; ENZYME INHIBITORS; FEEDING BEHAVIOR; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; OLEIC ACIDS; POLYUNSATURATED ALKAMIDES; PPAR ALPHA; RATS; RATS, WISTAR;

EID: 15744385109     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.078980     Document Type: Article

References (33)

1. Batkai S, Pacher P, Osei-Hyiaman D, Radaeva S, Liu J, Harvey-White J, Offertaler L, Mackie K, Rudd MA, Bukoski RD, et al. (2004) Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation 110:1996-2002.
2. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, and Piomelli D (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science (Wash DC) 277:1094-1097.
3. Burton MJ, Cooper SJ, and Popplewell DA (1981) The effect of fenfluramine on the microstructure of feeding and drinking in the rat. Br J Pharmacol 72:621-633.
4. Calignano A, La Rana G, Giuffrida A, and Piomelli D (1998) Control of pain initiation by endogenous cannabinoids. Nature (Lond) 394:277-281.
5. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, and Lichtman AH (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98:9371-9376.
6. Cravatt BF and Lichtman AH (2002) The enzymatic inactivation of the fatty acid amide class of signaling lipids. Chem Phys Lipids 121:135-148.
7. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Wash DC) 258:1946-1949.
8. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, and Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature (Lond) 372:686-691.
9. Fegley D, Kathuria S, Mercier R, Li C, Goutopoulos A, Makriyannis A, and Piomelli D (2004) Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc Natl Acad Sci USA 101:8756-8761.
10. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodríguez De Fonseca F, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, et al. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature (Lond) 425:90-93.
11. Gaetani S, Oveisi F, and Piomelli D (2003) Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacology 28:1311-1316.
12. Giuffrida A, Rodríguez de Fonseca F, and Piomelli D (2000) Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal Biochem 280:87-93.
13. Gomez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, and Rodríguez de Fonseca F (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22:9612-9617.
14. Hillard CJ, Edgemond WS, Jarrahian A, and Campbell WB (1997) Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J Neurochem 69:631-638.
15. Izzo AA, Fezza F, Capasso R, Bisogno T, Pinto L, luvone T, Esposito G, Mascolo N, Di Marzo V, and Capasso F (2001) Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. Br J Pharmacol 134:563-570.
16. Jaggar SI, Hasnie FS, Sellaturay S, and Rice AS (1998) The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 76:189-199.
17. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, et al. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76-81.
18. Kuehl FA, Jacob TA, Ganley OH, Ormond RE, and Meisinger MAP (1957) The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent. J Am Chem Soc 79:5577-5578.
19. Lichtman AH, Shelton CC, Advani T, and Cravatt BF (2004) Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain 109:319-327.
20. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90.
21. Mor M, Rivara S, Lodola A, Plazzi PV, Tarzia G, Duranti A, Tontini A, Piersanti G, Kathuria S, and Piomelli D (2004) Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships and molecular modeling studies. J Med Chem 47:4998-5008.
22. Okamoto Y, Morishita J, Tsuboi K, Tonai T, and Ueda N (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279:5298-5305.
23. Ortega-Gutierrez S, Hawkins EG, Viso A, Lopez-Rodríguez ML, and Cravatt BF (2004) Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake. Biochemistry 43:8184-8190.
24. Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873-884.
25. Rawls SM, Cabassa J, Geller EB, and Adler MW (2002) CB(1) receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl- 4(4-morpholinylmethyl)-1-(1-naphthalenyl- carbonyl)-6H-pyrrolo[3,2,1ij]quinolin- 6-one]-induced hypothermia. J Pharmacol Exp Ther 301:963-968.
26. Reidelberger RD, Arnelo U, Granqvist L, and Permert J (2001) Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 280:R605-R611.
27. Rodríguez de Fonseca F, Navarro M, Gomez R, Escuredo L, Nava F, Fu J, Murillo-Rodríguez E, Giuffrida A, LoVerme J, Gaetani S, et al. (2001) An anorexic lipid mediator regulated by feeding. Nature (Lond) 414:209-212.
28. Schmid HH, Schmid PC, and Natarajan V (1996) The N-acylation- phosphodiesterase pathway and cell signalling. Chem Phys Lipids 80:133-142.
29. Stella N, Schweitzer P, and Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature (Lond) 388:773-778.
30. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, and Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97.
31. Tarzia G, Duranti A, Tontini A, Piersanti G, Mor M, Rivara S, Plazzi PV, Park C, Kathuria S, and Piomelli D (2003) Design, synthesis and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors. J Med Chem 46:2352-2360.
32. Ueda N, Yamanaka K, Terasawa Y, and Yamamoto S (1999) An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors. FEBS Lett 454:267-270.
33. Ueda N, Yamanaka K, and Yamamoto S (2001) Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. J Biol Chem 276:35552-35557.